ATE284677T1 - Herstellung von pulveragglomeraten - Google Patents

Herstellung von pulveragglomeraten

Info

Publication number
ATE284677T1
ATE284677T1 AT98911423T AT98911423T ATE284677T1 AT E284677 T1 ATE284677 T1 AT E284677T1 AT 98911423 T AT98911423 T AT 98911423T AT 98911423 T AT98911423 T AT 98911423T AT E284677 T1 ATE284677 T1 AT E284677T1
Authority
AT
Austria
Prior art keywords
production
powder agglomerates
agglomerates
powder
Prior art date
Application number
AT98911423T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284677(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE284677T1 publication Critical patent/ATE284677T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98911423T 1997-03-20 1998-03-16 Herstellung von pulveragglomeraten ATE284677T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20
PCT/US1998/003799 WO1998041193A1 (en) 1997-03-20 1998-03-16 Preparation of powder agglomerates

Publications (1)

Publication Number Publication Date
ATE284677T1 true ATE284677T1 (de) 2005-01-15

Family

ID=25232603

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98911423T ATE284677T1 (de) 1997-03-20 1998-03-16 Herstellung von pulveragglomeraten
AT03020466T ATE415149T1 (de) 1997-03-20 1998-03-16 Dosierungsform eines pulveragglomerates

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03020466T ATE415149T1 (de) 1997-03-20 1998-03-16 Dosierungsform eines pulveragglomerates

Country Status (26)

Country Link
EP (3) EP2036544B1 (de)
JP (5) JP3901738B2 (de)
KR (1) KR100386055B1 (de)
CN (3) CN1149076C (de)
AR (1) AR011986A1 (de)
AT (2) ATE284677T1 (de)
AU (1) AU741783B2 (de)
CA (3) CA2282360C (de)
CL (1) CL2011000050A1 (de)
CZ (1) CZ295460B6 (de)
DE (2) DE69840277D1 (de)
DK (2) DK0969816T3 (de)
ES (2) ES2234102T3 (de)
HK (2) HK1021323A1 (de)
HU (2) HU230274B1 (de)
ID (1) ID24472A (de)
IL (1) IL131640A0 (de)
MY (1) MY120725A (de)
NO (1) NO328062B1 (de)
NZ (1) NZ337443A (de)
PL (3) PL192441B1 (de)
PT (2) PT969816E (de)
SK (1) SK284919B6 (de)
TW (1) TWI221778B (de)
WO (1) WO1998041193A1 (de)
ZA (1) ZA982254B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
JP2003526629A (ja) * 1999-08-20 2003-09-09 ノートン ヘルスケアー リミテッド 経肺または経鼻投与のための粉末の製造法
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (de) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
JP2007506768A (ja) * 2003-09-26 2007-03-22 シェーリング　コーポレイション 肺疾患処置
EP1686960A4 (de) * 2003-10-28 2007-03-07 Glaxo Group Ltd Inhalbierbare pharmazeutische formulierungen mit lactoseanhydrat und verabreichungsverfahren dafür
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
PT1691787E (pt) * 2003-12-04 2008-09-02 Pfizer Prod Inc Método de formação de multipartículas farmacêuticas
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
AU2010238641A1 (en) * 2009-04-24 2011-11-10 Merck Sharp & Dohme Corp. Agglomerate formulations useful in dry powder inhalers
TWI792140B (zh) 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
HUE038555T2 (hu) * 2010-04-21 2018-10-29 Chiesi Farm Spa Eljárás csökkentett elektrosztatikus töltéssel rendelkezõ részecskék elõállítására
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
EP3212212B1 (de) 2014-10-31 2020-09-23 Monash University Puderzubereitung
ES2973972T3 (es) * 2016-01-08 2024-06-25 Theron Pharmaceuticals Inc Composiciones de derivados de 7-azoniabiciclo[2.2.1]heptano para inhaladores de polvo seco

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
CA2123909C (en) * 1991-12-18 2002-10-01 Christer Carl Gustav Carling New combination of formoterol and budesonide
MY115140A (en) * 1992-12-18 2003-04-30 Schering Corp Inhaler for powdered medications
AU679789B2 (en) * 1993-10-01 1997-07-10 Astra Aktiebolag Process I
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
BR9510516A (pt) * 1994-12-22 1998-07-07 Astra Ab Preparação terapêutica uso da mesma dispositivo de inalação de pó seco processo de produção da preparação terapêutica e de tratamento de osteoporose

Also Published As

Publication number Publication date
NO994519L (no) 1999-11-19
CN100518718C (zh) 2009-07-29
CZ323399A3 (cs) 2000-02-16
ID24472A (id) 2000-07-20
PL335742A1 (en) 2000-05-08
DK0969816T3 (da) 2005-03-14
HU230274B1 (hu) 2015-11-30
ES2316681T3 (es) 2009-04-16
DE69828155D1 (de) 2005-01-20
ZA982254B (en) 1998-09-17
AU741783B2 (en) 2001-12-06
CA2706634A1 (en) 1998-09-24
WO1998041193A1 (en) 1998-09-24
ATE415149T1 (de) 2008-12-15
CA2282360A1 (en) 1998-09-24
EP0969816A1 (de) 2000-01-12
CL2011000050A1 (es) 2011-06-24
JP5523240B2 (ja) 2014-06-18
EP2036544B1 (de) 2016-12-28
NO328062B1 (no) 2009-11-13
CA2481868A1 (en) 1998-09-24
KR100386055B1 (ko) 2003-06-09
CA2282360C (en) 2004-11-09
DK1393721T3 (da) 2009-03-30
HU0600845D0 (en) 2007-01-29
AR011986A1 (es) 2000-09-13
CA2481868C (en) 2010-06-15
PT1393721E (pt) 2009-02-02
JP2010275316A (ja) 2010-12-09
EP1393721B1 (de) 2008-11-26
CN100548277C (zh) 2009-10-14
CN1552310A (zh) 2004-12-08
ES2234102T3 (es) 2005-06-16
EP1393721A1 (de) 2004-03-03
KR20010005520A (ko) 2001-01-15
JP2000510478A (ja) 2000-08-15
IL131640A0 (en) 2001-01-28
JP2010248260A (ja) 2010-11-04
EP2036544A1 (de) 2009-03-18
CN1903179A (zh) 2007-01-31
DE69840277D1 (de) 2009-01-08
EP0969816B1 (de) 2004-12-15
JP2006152000A (ja) 2006-06-15
CZ295460B6 (cs) 2005-08-17
MY120725A (en) 2005-11-30
NZ337443A (en) 2001-04-27
PT969816E (pt) 2005-04-29
AU6537898A (en) 1998-10-12
PL204480B1 (pl) 2010-01-29
DE69828155T2 (de) 2005-12-22
HUP0002029A2 (hu) 2000-11-28
PL192441B1 (pl) 2006-10-31
SK128099A3 (en) 2000-06-12
PL208480B1 (pl) 2011-05-31
CN1257423A (zh) 2000-06-21
SK284919B6 (sk) 2006-02-02
HK1061359A1 (en) 2004-09-17
NO994519D0 (no) 1999-09-17
TWI221778B (en) 2004-10-11
CN1149076C (zh) 2004-05-12
JP3901738B2 (ja) 2007-04-04
HUP0002029A3 (en) 2001-02-28
CA2706634C (en) 2012-10-23
JP2014037446A (ja) 2014-02-27
HK1021323A1 (en) 2000-06-09
HU226671B1 (en) 2009-06-29

Similar Documents

Publication Publication Date Title
ATE284677T1 (de) Herstellung von pulveragglomeraten
DE69738916D1 (de) Herstellung von pulverförmigem Material
DE69822186D1 (de) Herstellung von mustern
DE69816670D1 (de) Herstellung von alkylaromaten
DE59802696D1 (de) Herstellung von Carotinoiden
DE69722286D1 (de) Die Herstellung von Zwavel-enthaltende Organosiliziumverbindungen
DE69812901D1 (de) Katalytische herstellung von pentafluorpropenen
DE69827005D1 (de) Herstellung von waschmittelgranulaten
DE69814388D1 (de) Herstellung von waschmittelgranulaten
DE69827788D1 (de) Herstellung von hydroxyurethanen
DE59806703D1 (de) Herstellung von Formteilen
DE59806485D1 (de) Herstellung von Ascorbylmonophosphaten
DE69801392D1 (de) Herstellung von Methylchlorid
DE69804457D1 (de) Herstellung von waschmittelgranulaten
DE69804513D1 (de) Herstellung von zeolith-l
DE69715054D1 (de) Herstellung von Silanen
ATE365805T1 (de) Herstellung von l(+)-lactat
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln
DE69922558D1 (de) Herstellung von Aluminiumoxid
DE59800042D1 (de) Redispergierbare Pulverzusammensetzungen zur Herstellung von fotografischen Aufzeichnungsmaterialien
DE69502001D1 (de) Herstellung von uranoxid
DE69813402D1 (de) Herstellung von Alkylhalogensilanen
DE69809433D1 (de) Herstellung von avermectin-verbindungen
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE69808866D1 (de) Herstellung von Titanschlacke

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0969816

Country of ref document: EP